NCT00006190View on ClinicalTrials.gov

A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2000

Study Completion Date

November 30, 2001

Conditions
HIV InfectionsLipodystrophy
Interventions
DRUG

Nelfinavir mesylate

DRUG

Stavudine

DRUG

Lamivudine

DRUG

Efavirenz

Trial Locations (1)

75390-9103

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006190 - A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy | Biotech Hunter | Biotech Hunter